320 related articles for article (PubMed ID: 16629519)
1. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
2. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ of breast: detection and treatment pattern in Hong Kong.
Yau TK; Chan A; Cheung PS
Hong Kong Med J; 2017 Feb; 23(1):19-27. PubMed ID: 27779099
[TBL] [Abstract][Full Text] [Related]
4. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
[TBL] [Abstract][Full Text] [Related]
5. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
[TBL] [Abstract][Full Text] [Related]
6. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
[TBL] [Abstract][Full Text] [Related]
7. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
8. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.
Jacklyn G; Morrell S; McGeechan K; Houssami N; Irwig L; Pathmanathan N; Barratt A
Breast; 2018 Feb; 37():170-178. PubMed ID: 28882419
[TBL] [Abstract][Full Text] [Related]
11. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
[TBL] [Abstract][Full Text] [Related]
13. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
[TBL] [Abstract][Full Text] [Related]
14. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
15. Five-year risk of interval-invasive second breast cancer.
Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
[TBL] [Abstract][Full Text] [Related]
16. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
18. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
[TBL] [Abstract][Full Text] [Related]
19. Risk profile of breast cancer following atypical hyperplasia detected through organized screening.
Buckley E; Sullivan T; Farshid G; Hiller J; Roder D
Breast; 2015 Jun; 24(3):208-12. PubMed ID: 25681318
[TBL] [Abstract][Full Text] [Related]
20. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
